Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR Evotec SE (EVT.MU) Follow Add holdings 7.41 -0.19 (-2.55%) At close: April 25 at 8:00:51 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for EVT.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: EVT.MU View More All News Press Releases SEC Filings Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb Evotec SE (EVO) (Q4 2024) Earnings Call Highlights: Strong Q4 Performance and Strategic ... Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025 Is Evotec (EVO) the Best German Stock to Buy According to Hedge Funds? Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb Evotec Announces Change in Management Board Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk Sector Update: Health Care Stocks Rise in Afternoon Trading HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up